Recent Updates
Recently added Catalysts
BCAX Positive Sentiment Score: 75/100

Bicara Therapeutics to Present at the Stifel 2024 Healthcare Conference

Monday, November 11, 2024 1 min read
Key Takeaway: Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, will present at the Stifel 2024 Healthcare Conference in New York on November 19, 2024. The CEO, Claire Mazumdar, is expected to lead the presentation, highlighting the company's work on bifunctional therapies for solid tumors. A live webcast will be available on their website, with an archived version accessible for 90 days post-event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Bicara Therapeutics is presenting at a major healthcare conference, showcasing their advancements.
  • The CEO's involvement highlights the importance of the event for the company's visibility.
  • The webcast allows for broader accessibility to their presentation, potentially attracting interest.

Full Press Release Details

BOSTON, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies for patients with solid tumors, today announced that Claire Mazumdar, PhD, MBA, Chief Executive Officer of Bicara Therapeutics, will present at the Stifel 2024 Healthcare Conference in New York, NY on Tuesday, November 19, 2024 at 9:10 a.m. ET.
A live webcast of the presentation will be available on the Events and Presentations section of Bicara’s website at www.bicara.com. An archived replay of the webcast will be available for approximately 90 days following the presentation.
About Bicara Therapeutics

Frequently Asked Questions

When will Bicara Therapeutics present at the Stifel Conference?

Bicara Therapeutics will present on November 19, 2024, at 9:10 a.m. ET.

How can I watch the Bicara presentation live?

The presentation can be streamed live on Bicara's website.

Is there a replay available for the Bicara presentation?

Yes, an archived replay will be available for about 90 days post-presentation.

Who is presenting for Bicara Therapeutics?

Claire Mazumdar, PhD, MBA, will represent Bicara Therapeutics.

What is the focus of Bicara Therapeutics?

Bicara Therapeutics develops bifunctional therapies for solid tumors.

Tags: BCAX Viatris Investor Conferences Healthcare Bicara Therapeutics Stifel 2024 healthcare conference bifunctional therapies
Last updated: Nov 11, 2024